Skin Tight: Dermatology Specialty Leo Pharma To Buy Peplin for $287.5 Million
This article was originally published in The Pink Sheet Daily
Executive Summary
The dermatology market is increasingly attractive for deal makers, as Leo's all-cash acquisition of Peplin demonstrates.